| 1 |
35510306 | Optochemical Control of Therapeutic Agents through Photocatalyzed Isomerization. | 2022 May 4 |
1 |
| 2 |
33414428 | A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature. | 2021 Jan 4 |
1 |
| 3 |
34342437 | Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs? | 2021 Aug 12 |
1 |
| 4 |
31459105 | Combretastatin-Inspired Heterocycles as Antitubulin Anticancer Agents. | 2018 Aug 31 |
1 |
| 5 |
30108866 | Deciphering the origins of molecular toxicity of combretastatin A4 and its glycoconjugates: interactions with major drug transporters and their safety profiles in vitro and in vivo. | 2017 Jul 1 |
3 |
| 6 |
27212068 | Synthesis and biological activity of pyrrole analogues of combretastatin A-4. | 2016 Jul 1 |
1 |
| 7 |
25365233 | Recent advances in vascular disrupting agents in cancer therapy. | 2014 Sep |
1 |
| 8 |
22304851 | Increased endothelial cell selectivity of triazole-bridged dihalogenated A-ring analogues of combretastatin A-1. | 2012 Mar 1 |
1 |
| 9 |
16510288 | Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation. | 2006 Jun 15 |
1 |
| 10 |
15689156 | Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines. | 2005 Feb 10 |
1 |